Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.74 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.60 |
| ▸ | L3MBTL1 | Q9Y468 | 4/20 | 0.53 |
| ▸ | POLB | P06746 | 3/20 | 0.53 |
| ▸ | RECQL | P46063 | 1/20 | 0.53 |
| ▸ | BLM | P54132 | 1/20 | 0.53 |
| ▸ | BAZ1A | Q9NRL2 | 1/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.50 |
| ▸ | HTT | P42858 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.48 |
| ▸ | MEN1 | O00255 | 2/20 | 0.48 |
| ▸ | MAPT | P10636 | 2/20 | 0.48 |
| ▸ | CA12 | O43570 | 1/20 | 0.48 |
| ▸ | BRD4 | O60885 | 1/20 | 0.48 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.48 |
| ▸ | CA1 | P00915 | 1/20 | 0.48 |
| ▸ | CA2 | P00918 | 1/20 | 0.48 |
| ▸ | MB | P02144 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17084525 | 0.93 | RXFP1 (0.67) | RXFP1TDP1L3MBTL1POLBRECQL | |
| SCHEMBL959539 | 0.91 | RXFP1 (0.65) | RXFP1TDP1L3MBTL1POLBRECQL | |
| SCHEMBL124216 | 0.91 | RXFP1 (0.65) | RXFP1TDP1L3MBTL1POLBRECQL | |
| SCHEMBL6834332 | 0.89 | RXFP1 (0.62) | RXFP1TDP1L3MBTL1POLBRECQL | |
| Hydrochloric Acid SCHEMBL7460090 | 0.89 | RXFP1 (0.62) | RXFP1TDP1L3MBTL1POLBRECQL | |
| SCHEMBL7800028 | 0.89 | TDP1 (0.66) | RXFP1TDP1L3MBTL1POLBALDH1A1 | |
| SCHEMBL17299114 | 0.89 | RXFP1 (0.62) | RXFP1TDP1L3MBTL1POLBRECQL | |
| SCHEMBL8164496 | 0.89 | RXFP1 (0.62) | RXFP1TDP1L3MBTL1POLBRECQL | |
| SCHEMBL5071228 | 0.89 | RXFP1 (0.62) | RXFP1TDP1L3MBTL1POLBRECQL | |
| SCHEMBL3298240 | 0.89 | RXFP1 (0.62) | RXFP1TDP1L3MBTL1POLBRECQL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025061713-A1 | COMPOSITION AND METHOD OF 3D PRINTING A POROUS, SUBSTANCE-EMBOSSED MATERIAL, POROUS, SUBSTANCE-EMBOSSED MATERIAL, AND USES THEREOF | UNIVERSITÄT ULM (DE) | 2025-03-27 | — | — | WO | claimed |
| EP-2938641-B1 | MOLECULARLY IMPRINTED POLYMERS AND THEIR USE AS ANTIDANDRUFF AGENTS | ORÉAL L (FR) | 2016-08-24 | — | — | EP | claimed |
| US-7071240-B1 | Carboxylic cationites and methods of manufacture | POLYGRAN LTD. (IL) | 2006-07-04 | — | — | US | claimed |
| US-20040062745-A1 | Molecularly imprinted polymers for the treatment and diagnosis of medical conditions | GREEN BERNARD S (IL) | 2004-04-01 | — | — | US | claimed |
| US-6638498-B2 | A compound, comprising a molecularly imprinted polymer featuring at least one functional monomer selected from the vinyl hydroxypyridine; monomers selected from 4-vinylbenzamide and N-alkyl or N,N-dialkyl derivatives | SEMOREX INC. | 2003-10-28 | — | — | US | claimed |
| US-20020015690-A1 | Molecularly imprinted polymers for the treatment and diagnosis of medical conditions | SEMOREX INC. | 2002-02-07 | — | — | US | claimed |
| WO-2025061713-A1 | COMPOSITION AND METHOD OF 3D PRINTING A POROUS, SUBSTANCE-EMBOSSED MATERIAL, POROUS, SUBSTANCE-EMBOSSED MATERIAL, AND USES THEREOF | UNIVERSITÄT ULM (DE) | 2025-03-27 | — | — | WO | disclosed |
| US-20230190613-A1 | SKIN PERFECTING COSMETIC COMPOSITIONS AND METHODS OF USE | L'OREAL (FR) | 2023-06-22 | — | — | US | disclosed |
| WO-2022261721-A1 | HEALABLE AND REPROCESSABLE COMPOSITIONS | DEAKIN UNIVERSITY (AU) | 2022-12-22 | — | — | WO | disclosed |
| EP-3313566-B1 | PREPARATION OF MOLECULARLY IMPRINTED POLYMERS BY TWO-PHOTON STEREOLITHOGRAPHY | CENTRE NAT RECH SCIENT (FR) | 2019-06-05 | — | — | EP | disclosed |
| US-9983441-B2 | Liquid crystal display device | MERCK PATENT GMBH (DE) | 2018-05-29 | — | — | US | disclosed |
| EP-3313566-A1 | PREPARATION OF MOLECULARLY IMPRINTED POLYMERS BY TWO-PHOTON STEREOLITHOGRAPHY | Centre National De La Recherche Scientifique (FR) | 2018-05-02 | — | — | EP | disclosed |
| WO-2017001451-A1 | PREPARATION OF MOLECULARLY IMPRINTED POLYMERS BY TWO-PHOTON STEREOLITHOGRAPHY | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2017-01-05 | — | — | WO | disclosed |
| US-20040062745-A1 | Molecularly imprinted polymers for the treatment and diagnosis of medical conditions | GREEN BERNARD S (IL) | 2004-04-01 | — | — | US | disclosed |
| US-6638498-B2 | A compound, comprising a molecularly imprinted polymer featuring at least one functional monomer selected from the vinyl hydroxypyridine; monomers selected from 4-vinylbenzamide and N-alkyl or N,N-dialkyl derivatives | SEMOREX INC. | 2003-10-28 | — | — | US | disclosed |
| US-20020160295-A1 | Recording negatives; lithography printing plates; mixture of addiiton polymer and binder | FUJIFILM CORPORATION (JP) | 2002-10-31 | — | — | US | disclosed |
| EP-1235107-A1 | Photopolymerizable composition | FUJI PHOTO FILM CO., LTD. (JP) | 2002-08-28 | — | — | EP | disclosed |
| US-20020015690-A1 | Molecularly imprinted polymers for the treatment and diagnosis of medical conditions | SEMOREX INC. | 2002-02-07 | — | — | US | disclosed |
| US-4384011-A | Process for producing gravure printing plates | DAI NIPPON INSATSU KABUSHIKI KAISHA (JP) | 1983-05-17 | — | — | US | disclosed |
| US-4021404-A | AMIDES, NATURAL AND SYNTHETIC RUBBERS | THE GOODYEAR TIRE & RUBBER COMPANY (US) | 1977-05-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230190613-A1 | SKIN PERFECTING COSMETIC COMPOSITIONS AND METHODS OF USE | CUTA, ELOVL3, ELOVL1 | RXFP1 2400/4885TDP1 1468/4885L3MBTL1 1843/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.